▶ 調査レポート

呼吸器用薬の世界市場:市場規模・現状・予測

• 英文タイトル:Global Respiratory Drugs Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。呼吸器用薬の世界市場:市場規模・現状・予測 / Global Respiratory Drugs Market Size, Status and Forecast 2019-2025 / QYR9ST03983資料のイメージです。• レポートコード:QYR9ST03983
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、90ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、呼吸器用薬の世界市場について調査・分析し、呼吸器用薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(喘息、慢性閉塞性肺疾患、特発性肺線維症、嚢胞性線維症)、用途別(病院、外来診療、その他)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の呼吸器用薬市場動向
・主要企業別マーケットシェア
・呼吸器用薬の種類別市場規模2014-2019
(喘息、慢性閉塞性肺疾患、特発性肺線維症、嚢胞性線維症)
・呼吸器用薬の用途別市場規模2014-2019
(病院、外来診療、その他)
・呼吸器用薬の北米市場:主要企業・種類別/用途別市場規模
・呼吸器用薬のヨーロッパ市場:主要企業・種類別/用途別市場規模
・呼吸器用薬の中国市場:主要企業・種類別/用途別市場規模
・呼吸器用薬の日本国内市場:主要企業・種類別/用途別市場規模
・呼吸器用薬の東南アジア市場:主要企業・種類別/用途別市場規模
・呼吸器用薬のインド市場:主要企業・種類別/用途別市場規模
・呼吸器用薬の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Allied Healthcare、Cardinal Health、Covidien、Drager Medical、DeVilbiss Healthcare、Fisher & Paykel Healthcare、Getinge、Hamilton Medical、Invacare Corporation、nSpire Health、ResMed、Respironics)
・呼吸器用薬の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

In 2018, the global Respiratory Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of 4.1% during 2019-2025.
This report focuses on the global Respiratory Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Respiratory Drugs development in United States, Europe and China.

The key players covered in this study
Allied Healthcare
Cardinal Health
Covidien
Drager Medical
DeVilbiss Healthcare
Fisher & Paykel Healthcare
Getinge
Hamilton Medical
Invacare Corporation
nSpire Health
ResMed
Respironics

Market segment by Type, the product can be split into
Asthma
Chronic Obstructive Pulmonary Disease
Idiopathic Pulmonary Fibrosis
Cystic Fibrosis

Market segment by Application, split into
Hospitals
Ambulatory Care
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Respiratory Drugs status, future forecast, growth opportunity, key market and key players.
To present the Respiratory Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Respiratory Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Respiratory Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Asthma
1.4.3 Chronic Obstructive Pulmonary Disease
1.4.4 Idiopathic Pulmonary Fibrosis
1.4.5 Cystic Fibrosis
1.5 Market by Application
1.5.1 Global Respiratory Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Care
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Respiratory Drugs Market Size
2.2 Respiratory Drugs Growth Trends by Regions
2.2.1 Respiratory Drugs Market Size by Regions (2014-2025)
2.2.2 Respiratory Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Respiratory Drugs Market Size by Manufacturers
3.1.1 Global Respiratory Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Respiratory Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Respiratory Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Respiratory Drugs Key Players Head office and Area Served
3.3 Key Players Respiratory Drugs Product/Solution/Service
3.4 Date of Enter into Respiratory Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Respiratory Drugs Market Size by Type (2014-2019)
4.2 Global Respiratory Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Respiratory Drugs Market Size (2014-2019)
5.2 Respiratory Drugs Key Players in United States
5.3 United States Respiratory Drugs Market Size by Type
5.4 United States Respiratory Drugs Market Size by Application

6 Europe
6.1 Europe Respiratory Drugs Market Size (2014-2019)
6.2 Respiratory Drugs Key Players in Europe
6.3 Europe Respiratory Drugs Market Size by Type
6.4 Europe Respiratory Drugs Market Size by Application

7 China
7.1 China Respiratory Drugs Market Size (2014-2019)
7.2 Respiratory Drugs Key Players in China
7.3 China Respiratory Drugs Market Size by Type
7.4 China Respiratory Drugs Market Size by Application

8 Japan
8.1 Japan Respiratory Drugs Market Size (2014-2019)
8.2 Respiratory Drugs Key Players in Japan
8.3 Japan Respiratory Drugs Market Size by Type
8.4 Japan Respiratory Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Respiratory Drugs Market Size (2014-2019)
9.2 Respiratory Drugs Key Players in Southeast Asia
9.3 Southeast Asia Respiratory Drugs Market Size by Type
9.4 Southeast Asia Respiratory Drugs Market Size by Application

10 India
10.1 India Respiratory Drugs Market Size (2014-2019)
10.2 Respiratory Drugs Key Players in India
10.3 India Respiratory Drugs Market Size by Type
10.4 India Respiratory Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Respiratory Drugs Market Size (2014-2019)
11.2 Respiratory Drugs Key Players in Central & South America
11.3 Central & South America Respiratory Drugs Market Size by Type
11.4 Central & South America Respiratory Drugs Market Size by Application

12 International Players Profiles
12.1 Allied Healthcare
12.1.1 Allied Healthcare Company Details
12.1.2 Company Description and Business Overview
12.1.3 Respiratory Drugs Introduction
12.1.4 Allied Healthcare Revenue in Respiratory Drugs Business (2014-2019)
12.1.5 Allied Healthcare Recent Development
12.2 Cardinal Health
12.2.1 Cardinal Health Company Details
12.2.2 Company Description and Business Overview
12.2.3 Respiratory Drugs Introduction
12.2.4 Cardinal Health Revenue in Respiratory Drugs Business (2014-2019)
12.2.5 Cardinal Health Recent Development
12.3 Covidien
12.3.1 Covidien Company Details
12.3.2 Company Description and Business Overview
12.3.3 Respiratory Drugs Introduction
12.3.4 Covidien Revenue in Respiratory Drugs Business (2014-2019)
12.3.5 Covidien Recent Development
12.4 Drager Medical
12.4.1 Drager Medical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Respiratory Drugs Introduction
12.4.4 Drager Medical Revenue in Respiratory Drugs Business (2014-2019)
12.4.5 Drager Medical Recent Development
12.5 DeVilbiss Healthcare
12.5.1 DeVilbiss Healthcare Company Details
12.5.2 Company Description and Business Overview
12.5.3 Respiratory Drugs Introduction
12.5.4 DeVilbiss Healthcare Revenue in Respiratory Drugs Business (2014-2019)
12.5.5 DeVilbiss Healthcare Recent Development
12.6 Fisher & Paykel Healthcare
12.6.1 Fisher & Paykel Healthcare Company Details
12.6.2 Company Description and Business Overview
12.6.3 Respiratory Drugs Introduction
12.6.4 Fisher & Paykel Healthcare Revenue in Respiratory Drugs Business (2014-2019)
12.6.5 Fisher & Paykel Healthcare Recent Development
12.7 Getinge
12.7.1 Getinge Company Details
12.7.2 Company Description and Business Overview
12.7.3 Respiratory Drugs Introduction
12.7.4 Getinge Revenue in Respiratory Drugs Business (2014-2019)
12.7.5 Getinge Recent Development
12.8 Hamilton Medical
12.8.1 Hamilton Medical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Respiratory Drugs Introduction
12.8.4 Hamilton Medical Revenue in Respiratory Drugs Business (2014-2019)
12.8.5 Hamilton Medical Recent Development
12.9 Invacare Corporation
12.9.1 Invacare Corporation Company Details
12.9.2 Company Description and Business Overview
12.9.3 Respiratory Drugs Introduction
12.9.4 Invacare Corporation Revenue in Respiratory Drugs Business (2014-2019)
12.9.5 Invacare Corporation Recent Development
12.10 nSpire Health
12.10.1 nSpire Health Company Details
12.10.2 Company Description and Business Overview
12.10.3 Respiratory Drugs Introduction
12.10.4 nSpire Health Revenue in Respiratory Drugs Business (2014-2019)
12.10.5 nSpire Health Recent Development
12.11 ResMed
12.12 Respironics

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Respiratory Drugs Key Market Segments
Table Key Players Respiratory Drugs Covered
Table Global Respiratory Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Respiratory Drugs Market Size Market Share by Type 2014-2025
Figure Asthma Figures
Table Key Players of Asthma
Figure Chronic Obstructive Pulmonary Disease Figures
Table Key Players of Chronic Obstructive Pulmonary Disease
Figure Idiopathic Pulmonary Fibrosis Figures
Table Key Players of Idiopathic Pulmonary Fibrosis
Figure Cystic Fibrosis Figures
Table Key Players of Cystic Fibrosis
Table Global Respiratory Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Care Case Studies
Figure Others Case Studies
Figure Respiratory Drugs Report Years Considered
Table Global Respiratory Drugs Market Size 2014-2025 (Million US$)
Figure Global Respiratory Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Respiratory Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Respiratory Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Respiratory Drugs Market Share by Regions 2014-2019
Figure Global Respiratory Drugs Market Share by Regions 2014-2019
Figure Global Respiratory Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Respiratory Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Respiratory Drugs Market Share by Manufacturers (2014-2019)
Figure Global Respiratory Drugs Market Share by Manufacturers in 2018
Table Global Respiratory Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Respiratory Drugs Product/Solution/Service
Table Date of Enter into Respiratory Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Respiratory Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Respiratory Drugs Market Size Share by Type (2014-2019)
Figure Global Respiratory Drugs Market Size Market Share by Type (2014-2019)
Table Global Respiratory Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Respiratory Drugs Market Size Share by Application (2014-2019)
Figure Global Respiratory Drugs Market Size Market Share by Application (2014-2019)
Figure Global Respiratory Drugs Revenue Market Share by Application in 2018
Figure United States Respiratory Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Respiratory Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Respiratory Drugs Market Share (2018-2019)
Table United States Respiratory Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Respiratory Drugs Market Share by Type (2014-2019)
Table United States Respiratory Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Respiratory Drugs Market Share by Application (2014-2019)
Figure Europe Respiratory Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Respiratory Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Respiratory Drugs Market Share (2018-2019)
Table Europe Respiratory Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Respiratory Drugs Market Share by Type (2014-2019)
Table Europe Respiratory Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Respiratory Drugs Market Share by Application (2014-2019)
Figure China Respiratory Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Respiratory Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Respiratory Drugs Market Share (2018-2019)
Table China Respiratory Drugs Market Size by Type (2014-20189) (Million US$)
Table China Respiratory Drugs Market Share by Type (2014-2019)
Table China Respiratory Drugs Market Size by Application (2014-2019) (Million US$)
Table China Respiratory Drugs Market Share by Application (2014-2019)
Figure Japan Respiratory Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Respiratory Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Respiratory Drugs Market Share (2018-2019)
Table Japan Respiratory Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Respiratory Drugs Market Share by Type (2014-2019)
Table Japan Respiratory Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Respiratory Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Respiratory Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Respiratory Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Respiratory Drugs Market Share (2018-2019)
Table Southeast Asia Respiratory Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Respiratory Drugs Market Share by Type (2014-2019)
Table Southeast Asia Respiratory Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Respiratory Drugs Market Share by Application (2014-2019)
Figure India Respiratory Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Respiratory Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Respiratory Drugs Market Share (2018-2019)
Table India Respiratory Drugs Market Size by Type (2014-2019) (Million US$)
Table India Respiratory Drugs Market Share by Type (2014-2019)
Table India Respiratory Drugs Market Size by Application (2014-2019) (Million US$)
Table India Respiratory Drugs Market Share by Application (2014-2019)
Figure Central & South America Respiratory Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Respiratory Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Respiratory Drugs Market Share (2018-2019)
Table Central & South America Respiratory Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Respiratory Drugs Market Share by Type (2014-2019)
Table Central & South America Respiratory Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Respiratory Drugs Market Share by Application (2014-2019)
Table Allied Healthcare Company Details
Table Allied Healthcare Revenue in Respiratory Drugs Business (2014-2019) (Million US$)
Figure Allied Healthcare Revenue Growth Rate in Respiratory Drugs Business (2014-2019)
Table Allied Healthcare Recent Development
Table Cardinal Health Company Details
Table Cardinal Health Revenue in Respiratory Drugs Business (2014-2019)(Million US$)
Figure Cardinal Health Revenue Growth Rate in Respiratory Drugs Business (2014-2019)
Table Cardinal Health Recent Development
Table Covidien Company Details
Table Covidien Revenue in Respiratory Drugs Business (2014-2019)(Million US$)
Figure Covidien Revenue Growth Rate in Respiratory Drugs Business (2014-2019)
Table Covidien Recent Development
Table Drager Medical Company Details
Table Drager Medical Revenue in Respiratory Drugs Business (2014-2019)(Million US$)
Figure Drager Medical Revenue Growth Rate in Respiratory Drugs Business (2014-2019)
Table Drager Medical Recent Development
Table DeVilbiss Healthcare Company Details
Table DeVilbiss Healthcare Revenue in Respiratory Drugs Business (2014-2019)(Million US$)
Figure DeVilbiss Healthcare Revenue Growth Rate in Respiratory Drugs Business (2014-2019)
Table DeVilbiss Healthcare Recent Development
Table Fisher & Paykel Healthcare Company Details
Table Fisher & Paykel Healthcare Revenue in Respiratory Drugs Business (2014-2019)(Million US$)
Figure Fisher & Paykel Healthcare Revenue Growth Rate in Respiratory Drugs Business (2014-2019)
Table Fisher & Paykel Healthcare Recent Development
Table Getinge Company Details
Table Getinge Revenue in Respiratory Drugs Business (2014-2019)(Million US$)
Figure Getinge Revenue Growth Rate in Respiratory Drugs Business (2014-2019)
Table Getinge Recent Development
Table Hamilton Medical Company Details
Table Hamilton Medical Revenue in Respiratory Drugs Business (2014-2019)(Million US$)
Figure Hamilton Medical Revenue Growth Rate in Respiratory Drugs Business (2014-2019)
Table Hamilton Medical Recent Development
Table Invacare Corporation Company Details
Table Invacare Corporation Revenue in Respiratory Drugs Business (2014-2019)(Million US$)
Figure Invacare Corporation Revenue Growth Rate in Respiratory Drugs Business (2014-2019)
Table Invacare Corporation Recent Development
Table nSpire Health Company Details
Table nSpire Health Revenue in Respiratory Drugs Business (2014-2019)(Million US$)
Figure nSpire Health Revenue Growth Rate in Respiratory Drugs Business (2014-2019)
Table nSpire Health Recent Development
Table ResMed Company Details
Table Respironics Company Details
Table Global Respiratory Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Respiratory Drugs Market Size Share by Regions (2019-2025)
Figure Global Respiratory Drugs Market Size Share by Regions in 2025
Figure United States Respiratory Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Respiratory Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Respiratory Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Respiratory Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Respiratory Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Respiratory Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Respiratory Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Respiratory Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Respiratory Drugs Market Size by Product (2019-2025)
Figure Global Respiratory Drugs Market Size by Product in 2025
Table Global Respiratory Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Respiratory Drugs Market Size by Application (2019-2025)
Figure Global Respiratory Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources